US EditionUS judge in Hawaii considers legality of restrictions on access to abortion medication
- In 2017, a physician from Hawaii along with medical organizations filed a lawsuit in Honolulu disputing the FDA’s limitations on the abortion drug mifepristone.
- The case arises from FDA rules requiring special certification for prescribers and pharmacies, plus patients signing a counseling form, despite past removal of the in-person pickup rule.
- The ACLU argues these FDA restrictions disproportionately burden patients who face healthcare access challenges, especially low-income and rural individuals.
- Washington and 16 other states filed a citizen petition providing data on mifepristone safety, citing nearly 30,000 medication abortions in Washington with under 0.2% severe complications.
- The ongoing legal and political actions suggest continued debate over FDA policies could affect access to medication abortion nationwide under current federal regulations.
39 Articles
39 Articles
Washington Examiner
DailyTruthReportTime to face the truth about mifepristone
Last week, Costco announced it would not sell abortion-inducing Mifepristone at its 500-plus pharmacies, following a pressure campaign from conservative groups. Pro-life activists view this as a victory, but if it is, it’s incomplete. It does not do enough to protect the lives and health of women who use this drug. Our government should. Imagine a medication meant for women that caused a serious adverse outcome 11% of the time. Few women would r…
Federal judge in Hawaiʻi considers legality of abortion medication restrictions
The American Civil Liberties Union argues that the U.S. Food and Drug Administration continues to overly restrict access to mifepristone, a medication used for abortions and miscarriage management. A Hawaiʻi doctor and health care associations are suing over the restrictions.
Associated Press News
US judge in Hawaii considers legality of restrictions on access to abortion medication
The American Civil Liberties Union argues that the U.S. Food and Drug Administration continues to overly restrict access to mifepristone, a medication used for abortions and miscarriage management.
Judge in Hawaii considers legality of restrictions on access to abortion medication
The American Civil Liberties Union argues that the U.S. Food and Drug Administration continues to overly restrict access to mifepristone, a medication used for abortions and miscarriage management
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
